Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells. Issue 12 (6th November 2017)
- Record Type:
- Journal Article
- Title:
- Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells. Issue 12 (6th November 2017)
- Main Title:
- Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells
- Authors:
- Usui, Tatsuya
Sakurai, Masashi
Nishikawa, Shimpei
Umata, Koji
Nemoto, Yuki
Haraguchi, Tomoya
Itamoto, Kazuhito
Mizuno, Takuya
Noguchi, Shunsuke
Mori, Takashi
Iwai, Satomi
Nakagawa, Takayuki
Yamawaki, Hideyuki
Ohama, Takashi
Sato, Koichi - Abstract:
- Abstract : Dog spontaneously develop prostate cancer (PC) like humans. Because most dogs with PC have a poor prognosis, they could be used as a translational model for advanced PC in humans. Stem cell‐derived 3‐D organoid culture could recapitulate organ structures and physiology. Using patient tissues, a human PC organoid culture system was established. Recent study has shown that urine cells also possess the characteristic of stem cells. However, urine cell‐derived PC organoids have never been produced. Therefore, we generated PC organoids using the dog urine samples. Urine organoids were successfully generated from each dog with PC. Each organoid showed cystic structures and resembled the epithelial structures of original tissues. Expression of an epithelial cell marker, E‐cadherin, and a myofibloblast marker, α‐SMA, was observed in the urine organoids. The organoids also expressed a basal cell marker, CK5, and a luminal cell marker, CK8. CD49f‐sorted basal cell organoids rapidly grew compared with CD24‐sorted luminal cell organoids. The population of CD44‐positive cells was the highest in both organoids and the original urine cells. Tumors were successfully formed with the injection of the organoids into immunodeficient mice. Treatment with a microtubule inhibitor, docetaxel, but not a cyclooxygenase inhibitor, piroxicam, and an mTOR inhibitor, rapamycin, decreased the cell viability of organoids. Treatment with a Hedgehog signal inhibitor, GANT61, increased theAbstract : Dog spontaneously develop prostate cancer (PC) like humans. Because most dogs with PC have a poor prognosis, they could be used as a translational model for advanced PC in humans. Stem cell‐derived 3‐D organoid culture could recapitulate organ structures and physiology. Using patient tissues, a human PC organoid culture system was established. Recent study has shown that urine cells also possess the characteristic of stem cells. However, urine cell‐derived PC organoids have never been produced. Therefore, we generated PC organoids using the dog urine samples. Urine organoids were successfully generated from each dog with PC. Each organoid showed cystic structures and resembled the epithelial structures of original tissues. Expression of an epithelial cell marker, E‐cadherin, and a myofibloblast marker, α‐SMA, was observed in the urine organoids. The organoids also expressed a basal cell marker, CK5, and a luminal cell marker, CK8. CD49f‐sorted basal cell organoids rapidly grew compared with CD24‐sorted luminal cell organoids. The population of CD44‐positive cells was the highest in both organoids and the original urine cells. Tumors were successfully formed with the injection of the organoids into immunodeficient mice. Treatment with a microtubule inhibitor, docetaxel, but not a cyclooxygenase inhibitor, piroxicam, and an mTOR inhibitor, rapamycin, decreased the cell viability of organoids. Treatment with a Hedgehog signal inhibitor, GANT61, increased the radiosensitivity in the organoids. These findings revealed that PC organoids using urine might become a useful tool for investigating the mechanisms of the pathogenesis and treatment of PC in dogs. Abstract : In the present study, we for the first time generated the dog prostate cancer organoids using the urine samples. Our results suggest urine sample‐derived organoid culture system contributes to the treatment of not only dog prostate cancer but also human advanced prostate cancer. … (more)
- Is Part Of:
- Cancer science. Volume 108:Issue 12(2017)
- Journal:
- Cancer science
- Issue:
- Volume 108:Issue 12(2017)
- Issue Display:
- Volume 108, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 108
- Issue:
- 12
- Issue Sort Value:
- 2017-0108-0012-0000
- Page Start:
- 2383
- Page End:
- 2392
- Publication Date:
- 2017-11-06
- Subjects:
- Dog -- organoid -- prostate cancer -- stem cell -- urine
Cancer -- Periodicals
Neoplasms -- Periodicals
Research -- Periodicals
Electronic journals
616.994005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1347-9032;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1349-7006 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cas.13418 ↗
- Languages:
- English
- ISSNs:
- 1347-9032
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.603000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26533.xml